Boura C - Search Results

1

Sensitivity of glioma initiating cells to a monoclonal anti-EGFR antibody therapy under hypoxia.

Randriarimanana T, Chateau A, Faivre B, Pinel S, Boura C. Randriarimanana T, et al. Among authors: boura c. Life Sci. 2015 Sep 15;137:74-80. doi: 10.1016/j.lfs.2015.07.024. Epub 2015 Aug 1. Life Sci. 2015. PMID: 26239438

2

Cellular response to cetuximab in PTEN-silenced head and neck squamous cell carcinoma cell line.

Mriouah J, Boura C, Pinel S, Chretien AS, Fifre A, Merlin JL, Faivre B. Mriouah J, et al. Among authors: boura c. Int J Oncol. 2010 Dec;37(6):1555-63. doi: 10.3892/ijo_00000809. Int J Oncol. 2010. PMID: 21042725

3

Modulation of endothelial cell network formation in vitro by molecular signaling of head and neck squamous cell carcinoma (HNSCC) exposed to cetuximab.

Jouan-Hureaux V, Boura C, Merlin JL, Faivre B. Jouan-Hureaux V, et al. Among authors: boura c. Microvasc Res. 2012 Mar;83(2):131-7. doi: 10.1016/j.mvr.2011.07.008. Epub 2011 Jul 22. Microvasc Res. 2012. PMID: 21820450

4

Tumor vascular responses to antivascular and antiangiogenic strategies: looking for suitable models.

Mriouah J, Boura C, Thomassin M, Bastogne T, Dumas D, Faivre B, Barberi-Heyob M. Mriouah J, et al. Among authors: boura c. Trends Biotechnol. 2012 Dec;30(12):649-58. doi: 10.1016/j.tibtech.2012.08.006. Epub 2012 Sep 26. Trends Biotechnol. 2012. PMID: 23021636 Review.

5

PTEN expression is involved in the invasive properties of HNSCC: a key protein to consider in locoregional recurrence.

Mriouah J, Boura C, Gargouri M, Plénat F, Faivre B. Mriouah J, et al. Among authors: boura c. Int J Oncol. 2014 Mar;44(3):709-16. doi: 10.3892/ijo.2013.2219. Epub 2013 Dec 19. Int J Oncol. 2014. PMID: 24366426

6

Carbohydrate-based peptidomimetics targeting neuropilin-1: Synthesis, molecular docking study and in vitro biological activities.

Richard M, Chateau A, Jelsch C, Didierjean C, Manival X, Charron C, Maigret B, Barberi-Heyob M, Chapleur Y, Boura C, Pellegrini-Moïse N. Richard M, et al. Among authors: boura c. Bioorg Med Chem. 2016 Nov 1;24(21):5315-5325. doi: 10.1016/j.bmc.2016.08.052. Epub 2016 Aug 29. Bioorg Med Chem. 2016. PMID: 27622745

7

Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1.

Gong C, Valduga J, Chateau A, Richard M, Pellegrini-Moïse N, Barberi-Heyob M, Chastagner P, Boura C. Gong C, et al. Among authors: boura c. Oncotarget. 2018 Feb 16;9(20):15312-15325. doi: 10.18632/oncotarget.24521. eCollection 2018 Mar 16. Oncotarget. 2018. PMID: 29632646 Free PMC article.

8

Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment.

Pinel S, Thomas N, Boura C, Barberi-Heyob M. Pinel S, et al. Among authors: boura c. Adv Drug Deliv Rev. 2019 Jan 1;138:344-357. doi: 10.1016/j.addr.2018.10.013. Epub 2018 Nov 7. Adv Drug Deliv Rev. 2019. PMID: 30414495 Free article. Review.

9

Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cells.

Gauthier M, Laroye C, Bensoussan D, Boura C, Decot V. Gauthier M, et al. Among authors: boura c. Crit Rev Oncol Hematol. 2021 Apr;160:103261. doi: 10.1016/j.critrevonc.2021.103261. Epub 2021 Feb 16. Crit Rev Oncol Hematol. 2021. PMID: 33607229 Review.

10

Synthesis of anti-proliferative [3.3.0]furofuranone derivatives by lactonization and functionalization of C-glycosyl compounds.

Ariztia J, Chateau A, Boura C, Didierjean C, Lamandé-Langle S, Pellegrini Moïse N. Ariztia J, et al. Among authors: boura c. Bioorg Med Chem. 2021 Sep 1;45:116313. doi: 10.1016/j.bmc.2021.116313. Epub 2021 Jul 21. Bioorg Med Chem. 2021. PMID: 34325324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters